摘要:
sci-hub.se 参考文章(6)
Shigeto Kobayashi, Shyugo Ishizuka, Naoto Tamura, Makiyo Takaya, Kazuhiko Kaneda, Hiroshi Hashimoto, Churg–Strauss syndrome (CSS) in a patient receiving pranlukast Clinical Rheumatology. ,vol. 22, pp. 491- 492 ,(2003) , 10.1007/S10067-003-0791-5
William Berger, Niroo Gupta, Margaret McAlary, Angel Fowler-Taylor, Evaluation of long-term safety of the anti-IgE antibody, omalizumab, in children with allergic asthma. Annals of Allergy Asthma & Immunology. ,vol. 91, pp. 182- 188 ,(2003) , 10.1016/S1081-1206(10)62175-8
William Busse, Jonathan Corren, Bobby Quentin Lanier, Margaret McAlary, Angel Fowler-Taylor, Giovanni Della Cioppa, Andre van As, Niroo Gupta, Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. The Journal of Allergy and Clinical Immunology. ,vol. 108, pp. 184- 190 ,(2001) , 10.1067/MAI.2001.117880
R G STIRLING, K F CHUNG, Leukotriene antagonists and Churg-Strauss syndrome: the smoking gun Thorax. ,vol. 54, pp. 865- 866 ,(1999) , 10.1136/THX.54.10.865
Michael E Wechsler, Erik Garpestad, Steven R Flier, Olivier Kocher, David A Weiland, Albert J Polito, Michelle M Klinek, Timothy D Bigby, Gordon A Wong, Richard A Helmers, Jeffrey M Drazen, Pulmonary Infiltrates, Eosinophilia, and Cardiomyopathy Following Corticosteroid Withdrawal in Patients With Asthma Receiving Zafirlukast JAMA. ,vol. 279, pp. 455- 457 ,(1998) , 10.1001/JAMA.279.6.455
Robert C. Strunk, Gordon R. Bloomberg, Omalizumab for asthma. The New England Journal of Medicine. ,vol. 354, pp. 2689- 2695 ,(2006) , 10.1056/NEJMCT055184